Position in IMMX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$103,100
+$12,000 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 109 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $12,669,600 across 24 Biotechnology names. IMMX ranks #24 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,230 | $2,101,167 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,732 | $1,703,511 | |
| 3 | ARGX |
Argenx SE
|
1,311 | $1,216,306 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,952 | $1,048,126 | |
| 5 | INSM |
INSMED Inc
|
7,262 | $774,274 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
17,281 | $644,062 | |
| 7 | QURE |
uniQure N.V.
|
10,874 | $500,856 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,583 | $422,217 |
All Filings in IMMX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,100 | 10,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $91,100 | 10,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $52,300 | 10,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,900 | 10,000 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||